Galapagos N.V. - Asset Resilience Ratio

Latest as of September 2025: 85.02%

Galapagos N.V. (GLPG) has an Asset Resilience Ratio of 85.02% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Galapagos N.V. for a breakdown of total debt and financial obligations.

Liquid Assets

€3.51 Billion

≈ $4.10 Billion USD Cash + Short-term Investments

Total Assets

€4.13 Billion

≈ $4.82 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Galapagos N.V.'s Asset Resilience Ratio has changed over time. See shareholders equity of Galapagos N.V. for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Galapagos N.V.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Galapagos N.V. (GLPG) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€3.51 Billion	85.02%
Total Liquid Assets	€3.51 Billion	85.02%

Asset Resilience Insights

Very High Liquidity: Galapagos N.V. maintains exceptional liquid asset reserves at 85.02% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Galapagos N.V. Industry Peers by Asset Resilience Ratio

Compare Galapagos N.V.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	25.67%
Tubize-Fin BR:TUB	Biotechnology	0.05%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
Dashenlin Pharm Grp Co Ltd SHG:603233	Biotechnology	0.02%
Staidson Beijing Biopharma SHE:300204	Biotechnology	7.93%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	41.25%
Ardelyx Inc NASDAQ:ARDX	Biotechnology	41.14%
Xiangxue Pharmaceutical SHE:300147	Biotechnology	0.05%

Annual Asset Resilience Ratio for Galapagos N.V. (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Galapagos N.V..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	73.83%	€3.05 Billion ≈ $3.57 Billion	€4.14 Billion ≈ $4.84 Billion	-6.90pp
2023-12-31	80.73%	€3.52 Billion ≈ $4.11 Billion	€4.36 Billion ≈ $5.09 Billion	+4.99pp
2022-12-31	75.74%	€3.59 Billion ≈ $4.19 Billion	€4.73 Billion ≈ $5.53 Billion	+28.18pp
2021-12-31	47.56%	€2.47 Billion ≈ $2.89 Billion	€5.19 Billion ≈ $6.07 Billion	-5.37pp
2020-12-31	52.93%	€3.03 Billion ≈ $3.54 Billion	€5.72 Billion ≈ $6.68 Billion	-11.65pp
2019-12-31	64.58%	€3.92 Billion ≈ $4.58 Billion	€6.07 Billion ≈ $7.09 Billion	+63.98pp
2016-12-31	0.61%	€6.57 Million ≈ $7.68 Million	€1.08 Billion ≈ $1.27 Billion	-0.94pp
2015-12-31	1.55%	€6.86 Million ≈ $8.02 Million	€442.51 Million ≈ $517.35 Million	-2.30pp
2014-12-31	3.85%	€10.42 Million ≈ $12.18 Million	€270.47 Million ≈ $316.20 Million	--

pp = percentage points

About Galapagos N.V.

AS:GLPG Netherlands Biotechnology

Market Cap

$1.86 Billion

€1.59 Billion EUR

Market Cap Rank

#6546 Global

#47 in Netherlands

Share Price

€24.14

Change (1 day)

+0.67%

52-Week Range

€22.56 - €31.84

All Time High

€249.50